Sarah, a triple-negative breast cancer patient, found hope in generative AI, which delivered a personalized treatment plan validated by robust evidence.
This innovative approach not only saved her 15% in care costs but also ensured a smoother journey to recovery, minimizing side effects and maximizing her quality of life.